| Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. K Sasaki, TP Cripe, SR Koch, TL Andreone, DD Petersen, EG Beale, ... Journal of Biological Chemistry 259 (24), 15242-15251, 1984 | 522 | 1984 |
| Transcriptional regulation of the human papillomavirus‐16 E6‐E7 promoter by a keratinocyte‐dependent enhancer, and by viral E2 trans‐activator and repressor gene products … TP Cripe, TH Haugen, JP Turk, F Tabatabai, PG Schmid 3rd, M Dürst, ... The EMBO journal 6 (12), 3745-3753, 1987 | 493 | 1987 |
| MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors WJ Jessen, SJ Miller, E Jousma, J Wu, TA Rizvi, ME Brundage, D Eaves, ... The Journal of clinical investigation 123 (1), 340-347, 2013 | 357 | 2013 |
| Prognostic factors and outcomes for osteosarcoma: an international collaboration EE Pakos, AD Nearchou, RJ Grimer, HD Koumoullis, A Abudu, ... European journal of cancer 45 (13), 2367-2375, 2009 | 227 | 2009 |
| Transcriptional enhancer factor (TEF)‐1 and its cell‐specific co‐activator activate human papillomavirus‐16 E6 and E7 oncogene transcription in keratinocytes and cervical … T Ishiji, MJ Lace, S Parkkinen, RD Anderson, TH Haugen, TP Cripe, ... The EMBO journal 11 (6), 2271-2281, 1992 | 221 | 1992 |
| A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells JR Stehn, NK Haass, T Bonello, M Desouza, G Kottyan, H Treutlein, ... Cancer research 73 (16), 5169-5182, 2013 | 206 | 2013 |
| Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly M Li, TP Cripe, PA Estes, MK Lyon, RC Rose, RL Garcea Journal of virology 71 (4), 2988-2995, 1997 | 199 | 1997 |
| Trans‐activation of an upstream early gene promoter of bovine papilloma virus‐1 by a product of the viral E2 gene. TH Haugen, TP Cripe, GD Ginder, M Karin, LP Turek The EMBO journal 6 (1), 145-152, 1987 | 193 | 1987 |
| Evidence that a human β-tubulin pseudogene is derived from its corresponding mRNA CD Wilde, CE Crowther, TP Cripe, MGS Lee, NJ Cowan Nature 297 (5861), 83-84, 1982 | 190 | 1982 |
| Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients TP Cripe, MC Ngo, JI Geller, CU Louis, MA Currier, JM Racadio, ... Molecular Therapy 23 (3), 602-608, 2015 | 180 | 2015 |
| Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus YY Mahller, JP Williams, WH Baird, B Mitton, J Grossheim, Y Saeki, ... PloS one 4 (1), e4235, 2009 | 173 | 2009 |
| Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human … TP Cripe, EJ Dunphy, AD Holub, A Saini, NH Vasi, YY Mahller, ... Cancer research 61 (7), 2953-2960, 2001 | 172 | 2001 |
| Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A JA Toretsky, V Erkizan, A Levenson, OD Abaan, JD Parvin, TP Cripe, ... Cancer research 66 (11), 5574-5581, 2006 | 165 | 2006 |
| Immunotherapy for osteosarcoma: where do we go from here? MF Wedekind, LM Wagner, TP Cripe Pediatric blood & cancer 65 (9), e27227, 2018 | 148 | 2018 |
| In vivo and in vitro association of hsc70 with polyomavirus capsid proteins TP Cripe, SE Delos, PA Estes, RL Garcea Journal of virology 69 (12), 7807-7813, 1995 | 148 | 1995 |
| Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors G Johansson, YY Mahller, MH Collins, MO Kim, T Nobukuni, J Perentesis, ... Molecular cancer therapeutics 7 (5), 1237-1245, 2008 | 147 | 2008 |
| Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk … DO Walterhouse, AS Pappo, JL Meza, JC Breneman, AA Hayes-Jordan, ... Journal of Clinical Oncology 32 (31), 3547-3552, 2014 | 144 | 2014 |
| Intratumoral injection of HSV1716, an oncolytic herpes virus, is safe and shows evidence of immune response and viral replication in young cancer patients KA Streby, JI Geller, MA Currier, PS Warren, JM Racadio, AJ Towbin, ... Clinical Cancer Research 23 (14), 3566-3574, 2017 | 133 | 2017 |
| Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo TM Wise-Draper, RA Mintz-Cole, TA Morris, DS Simpson, ... Cancer research 69 (5), 1792-1799, 2009 | 130 | 2009 |
| Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules. TP Cripe, A Alderborn, RD Anderson, S Parkkinen, P Bergman, ... The New Biologist 2 (5), 450-463, 1990 | 126 | 1990 |